The use of pentoxifylline as adjuvant therapy with praziquantel downregulates profibrogenic cytokines, collagen deposition and oxidative stress in experimental schistosomiasis mansoni

Experimental Parasitology

Volumn 129, Issue 2, 2011, Pages 152-157

  El Lakkany, Naglaa ^a   Seif el Din, Sayed ^a   Ebeid, Fatma ^a  

^a Giza   (Egypt)

Author keywords

MMP 2; Oxidative stress; Pentoxiphylline; Praziquantel; Schistosoma mansoni

Indexed keywords

COLLAGEN; GELATINASE A; GLUTATHIONE; GLUTATHIONE PEROXIDASE; GLUTATHIONE REDUCTASE; GLUTATHIONE TRANSFERASE; HYDROXYPROLINE; MALONALDEHYDE; PENTOXIFYLLINE; PRAZIQUANTEL; SUPEROXIDE DISMUTASE; TRANSFORMING GROWTH FACTOR BETA1; TUMOR NECROSIS FACTOR ALPHA;

ADJUVANT THERAPY; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DOWN REGULATION; DRUG USE; LIVER FIBROSIS; MALE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; SCHISTOSOMA MANSONI; SCHISTOSOMIASIS MANSONI; TREATMENT DURATION; TREATMENT OUTCOME;

ANIMALS; COLLAGEN; CYTOKINES; DOWN-REGULATION; DRUG THERAPY, COMBINATION; FREE RADICAL SCAVENGERS; HYDROXYPROLINE; LIPID PEROXIDATION; LIVER; MALE; MATRIX METALLOPROTEINASE 2; MICE; OXIDATIVE STRESS; PENTOXIFYLLINE; PRAZIQUANTEL; RANDOM ALLOCATION; SCHISTOSOMIASIS MANSONI; SCHISTOSOMICIDES; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR-ALPHA;

ANIMALIA; MUS; SCHISTOSOMA MANSONI;

EID: 80052425114     PISSN: 00144894     EISSN: 10902449     Source Type: Journal    
DOI: 10.1016/j.exppara.2011.06.015     Document Type: Article

References (57)

1. Abdel-Tawab G., Aboul-Azm T., Ebeid S. The correlation between certain tryptophane metabolites and the N-nitrosamine content in the urine of bilharzial bladder cancer patients. Journal of Urology 1986, 135:826-830.
2. Alves Oliveira L.F., Moreno E.C., Gazzinelli G., Martins-Filho O.A., Silveira A.M., Gazzinelli A., Malaquias L.C., LoVerde P., Leite P.M., Correa-Oliveira R. Cytokine production associated with periportal fibrosis during chronic schistosomiasis mansoni in humans. Infection and Immunity 2006, 74:1215-1221.
3. Bataller R., Brenner D.A. Liver fibrosis. The Journal of Clinical Investigation 2005, 115:209-218.
4. Bergman I., Loxley R. Two improved and simplified methods for the spectrophotometric determination of hydroxyproline. Analytical Chemistry 1963, 35:1961-1965.
5. Berman B., Duncan M.R. Pentoxifylline inhibits normal human dermal fibroblast in vitro proliferation, collagen, glycosaminoglycan, and fibronectin production, and increases collagenase activity. The Journal of Investigative Dermatology 1989, 92:605-610.
6. Brenner D.A., O'Hara M., Angel P., Chojkier M., Karin M. Prolonged activation of jun and collagenase genes by tumor necrosis factor-alpha. Nature 1989, 337:661-663.
7. Chen H., He Y.W., Liu W.Q., Zhang J.H. Rosiglitazone prevents murine hepatic fibrosis induced by Schistosoma japonicum. World Journal of Gastroenterology 2008, 14:2905-2911.
8. Chen M.G. Use of praziquantel for clinical treatment and morbidity control of schistosomiasis japonica in China: a review of 30years' experience. Acta Tropica 2005, 96:168-176.
9. Duncan M.R., Hasan A., Berman B. Pentoxifylline, pentifylline, and interferons decrease type I and III procollagen mRNA levels in dermal fibroblasts: evidence for mediation by nuclear factor 1 down-regulation. The Journal of Investigative Dermatology 1995, 104:282-286.
10. El-lakkany N., Nosseir M. Pharmacodynamics of pentoxifylline and/or praziquantel in murine schistosomiasis mansoni. Acta, Pathologica, Microbiologica, et Immunologica Scandinavica 2007, 115:184-194.
11. Ellman G.L. Tissue sulfhydryl groups. Archives of Biochemistry and Biophysics 1959, 88:70-77.
12. Emonard H., Grimaud J.A. Active and latent collagenase activity during reversal of hepatic fibrosis in murine schistosomiasis. Hepatology 1989, 10:77-83.
13. Esterbauer H., Cheeseman K.H. Determination of Aldehydic Lipid Peroxidation Products: Malonalehyde and 4-hydroxynonenal 1990, 407-421. Academic Press, New York. L. Packer, A.N. Glazer (Eds.).
14. Fallon P.G., Doenhoff M.J. Active immunization of mice with Schistosoma mansoni worm membrane antigens enhances efficacy of praziquantel. Parasite Immunology 1995, 17:261-268.
15. Fallon P.G., Dunne D.W. Tolerization of mice to Schistosoma mansoni egg antigens causes elevated type 1 and diminished type 2 cytokine responses and increased mortality in acute infection. Journal of Immunology 1999, 162:4122-4132.
16. Fenwick A., Savioli L., Engels D., Bergquist R., Todd M.H. Drugs for the control of parasitic diseases: current status and development in schistosomiasis. Trends in Parasitology 2003, 19:509-515.
17. Galli A., Svegliati-Baroni G., Ceni E., Milani S., Ridolfi F., Salzano R., Tarocchi M., Grappone C., Pellegrini G., Benedetti A., Surrenti C., Casini A. Oxidative stress stimulates proliferation and invasiveness of hepatic stellate cells via a MMP2-mediated mechanism. Hepatology 2005, 41:1074-1084.
18. George J., Pera N., Phung N., Leclercq I., Yun Hou J., Farrell G. Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. Journal of Hepatology 2003, 39:756-764.
19. Gharib B., Abdallahi O.M., Dessein H., De Reggi M. Development of eosinophil peroxidase activity and concomitant alteration of the antioxidant defenses in the liver of mice infected with Schistosoma mansoni. Journal of Hepatology 1999, 30:594-602.
20. Gonnert R., Andrews P. Praziquantel, a new broad spectrum antischistosomal agent. Zeitschrift fur Parasitenkund 1977, 52:129-150.
21. Grimaud J.A., Boros D.L., Takiya C., Mathew R.C., Emonard H. Collagen isotypes, laminin, and fibronectin in granulomas of the liver and intestines of Schistosoma mansoni-infected mice. The American Journal of Tropical Medicine and Hygiene 1987, 37:335-344.
22. Gutierrez-Ruiz M.C., Gómez-Quiroz L.E. Liver fibrosis: searching for cell model answers. Liver International 2007, 27:434-439.
23. Habig W.M., Pabst M.J., Jakoby W.B. Glutathione-S-transferase: the first enzymatic step in mercapturic acid formation. The Journal of Biological Chemistry 1974, 249:7130-7139.
24. Hanna C., Dorota S., Michal S., Malgorzata P. Glutathione and GSH-dependent enzymes in patients with liver cirrhosis and hepatocellular carcinoma. Acta Biochimica Polonica 2006, 53:237-241.
25. Hirose Y., Kirinoki M., Matsuda H. Efficacy of administration of praziquantel on 2days 2weeks apart against Schistosoma japonicum eggs in mice. Parasitology International 2003, 52:141-146.
26. Koppe S.W., Sahai A., Malladi P., Whitington P.F., Green R.M. Pentoxifylline attenuates steatohepatitis induced by methionine cholin deficient diet. Journal of Hepatology 2004, 41:592-598.
27. Kozaki K., Egawa H., Bermudes L., Feduska N.J., SO S., Esquivel C.O. Pentoxifylline inhibits production of superoxide anion and tumor necrosis factor by Kupffer cells in rat liver preservation. Transplantation Proceedings 1993, 25:3025-3026.
28. Kwiecien S., Brzozowski T., Konturek P.C., Pawlik M.W., Pawlik W.W., Kwiecieñ N., Konturek S.J. Gastroprotection by pentoxyfilline against stress induced gastric damage. Role of lipid peroxidation, antioxidizing enzymes and proinflammatory cytokine. Journal of Physiology and Pharmacology 2004, 55:337-355.
29. Lambertucci J.R., Serufo J.C., Gerspacher-Lara R., Rayes A.A., Teixeira R., Nobre V., Antunes C.M. Schistosoma mansoni: assessment of morbidity before and after control. Acta Tropica 2000, 77:101-109.
30. Lenzi H.L., Kimmel E., Schechtman H., Pelajo-Machado M., Vale B.S., Panasco M.S., Lenzi J.A. Collagen arrangement in hepatic granuloma in mice infected with Schistosoma mansoni: dependence on fiber radiation centers. Brazilian Journal of Medical and Biological Research 1999, 32:639-643.
31. Liang, Y.S., John, B.I., Boyd, D.A., 1987. Laboratory cultivation of schistosome vector snails and maintenance of schistosome life cycles. Proceeding of the 1st Sino-American Symposium 1, 34-48.
32. Liu X., Wang W., Hu H., Tang N., Zhang C., Liang W., Wang M. Smad3 specific inhibitor, naringenin, decreases the expression of extracellular matrix induced by TGF-beta1 in cultured rat hepatic stellate cells. Pharmceutical Research 2006, 23:82-89.
33. Liu X., Wu H., Liu F., Huang M., Qiang O., Huang S. Effects of tumor necrosis factor alpha on the expression of connective tissue growth factor in hepatic stellate cells. Zhonghua Gan Zang Bing Za Zhi 2001, 9:15-17.
34. Loebermann M., Sombetzki M., Langner C., Fuchsbichler A., Gumhold J., Silbert D., Riebold D., Holtfreter M., Fickert P., Nizze H., Trauner M., Reisinger E.C. Imbalance of pro- and antifibrogenic genes and bile duct injury in murine Schistosoma mansoni infection-induced liver fibrosis. Tropical Medicine and International Health 2009, 14:1418-1425.
35. Lowry O.H., Rosebrough N.J., Farry A.L., Randall R.J. Protein measurement with Folin-phenol reagent. The Journal of Biological Chemistry 1951, 193:265-275.
36. Neuner P., Klosner G., Pourmojib M., Knobler R., Schwarz T. Pentoxifylline in vivo and in vitro downregulates the expression of the intercellular adhesion molecule-1 in monocytes. Immunology 1997, 90:435-439.
37. Okuno T., Andoh A., Bamba S., Araki Y., Fujiyama Y., Fujiyama M., Bamba T. Interleukin-1beta and tumor necrosis factor-alpha induce chemokine and matrix metalloproteinase gene expression in human colonic subepithelial myofibroblasts. Scandinavian Journal of Gastroenterology 2002, 37:317-324.
38. Paglia D.E., Valentine W.N. Studies on the quantitative and qualitative characterization of erythrocyte glutathione peroxidase. The Journal of Laboratory and Clinical Medicine 1967, 70:158-169.
39. Parola M., Muraca R., Dianzani I., Barrera G., Leonarduzzi G., Bendinelli P., Piccoletti R., Poli G. Vitamin E dietary supplementation inhibits transforming growth factor beta 1 gene expression in the rat liver. FEB Letters 1992, 308:267-270.
40. Peterson T.C. Pentoxifylline prevents fibrosis in an animal model and inhibits platelet-derived growth factor-driven proliferation of fibroblasts. Hepatology 1993, 17:486-493.
41. Peterson T.C., Neumeister M. Effect of pentoxifylline in rat and swine models of hepatic fibrosis: role of fibroproliferation in its mechanism. Immunopharmacology 1996, 31:183-193.
42. Raetsch C., Jia J.D., Boigk G., Bauer M., Hahn E.G., Riecken E.O., Schuppan D. Pentoxifylline downregulates profibrogenic cytokines and procollagen 1 expression in rat secondary biliary fibrosis. Gut 2002, 50:241-247.
43. Reddy G.K., Envenemeka C.S. A simplified method for the analysis of hydroxyproline in biological tissues. Clinical Biochemistry 1996, 29:225-229.
44. Reif S., Somech R., Brazovski E., Reich R., Belson A., Konikoff F.M., Kessler A. Matrix metalloproteinases 2 and 9 are markers of inflammation but not of the degree of fibrosis in chronic hepatitis C. Digestion 2005, 71:124-130.
45. Reis L.F., Ventura T.G., Souza S.O., Arana-Pino A., Pelajo-Machado M., Pereira M.J., Lenzi H.L., Conceição M.J., Takiya C.M. Quantitative and qualitative interferences of pentoxifylline on hepatic Schistosoma mansoni granulomas: effects on extracellular matrix and eosinophil population. Memorias do Instituto Oswaldo Cruz 2001, 96:107-112.
46. Romanelli R.G., Caligiuri A., Carloni V., DeFranco R., Montalto P., Ceni E., Casini A., Gentilini P., Pinzani M. Effect of pentoxifylline on the degradation of procollagen type I produced by human hepatic stellate cells in response to transforming growth factor-beta 1. British Journal of Pharmacology 1997, 122:1047-1054.
47. Savas S., Delibas N., Savas C.E., Sutcu R., Cindas A. Pentoxifylline reduces biochemical markers of ischemia-reperfusion induced spinal cord injury in rabbits. Spinal cord 2002, 40:224-229.
48. Schiller E.L., Haese W.H. Histologic processes of healing in hepatic injury due to eggs of Schistosoma mansoni in mice following curative chemotherapy. The American Journal of Tropical Medicine and Hygiene 1973, 22:211-214.
49. Seif el Din S.H. Prophylactic effect of artesunate with/without antioxidants on juvenile and adult Egyptian strain of Schistosoma mansoni in mice. Al-Azhar Journal of Pharmceutical Sciences 2007, 35:80-93.
50. Seif el-Din S.H., Ebeid F.A., Badawy A.A., Ezzat A.R. Protective effects of β-carotene, N-acetyl-cysteine with and without praziquantel treatment in Schistosoma mansoni-infected mice. Egyptian Journal of Schistosomiasis and Infectious and Endemic Diseases 2006, 28:67-90.
51. Singh K.P., Gerard H.C., Hudson A.P., Boros D.L. Expression of matrix metalloproteinases and their inhibitors during the resorption of schistosome egg-induced fibrosis in praziquantel-treated mice. Immunology 2004, 111:343-352.
52. Takahara T., Furui K., Yata Y., Jin B., Zhang L.P., Nambu S., Sato H., Seiki M., Watanabe A. Dual expression of matrix metalloproteinase-2 and membrane-type-1-matrix metalloproteinase in fibrotic human livers. Hepatology 1997, 26:1521-1529.
53. Wahl S.M., Frazier-Jessen M., Jin W.W., Kopp J.B., Sher A., Cheever A.W. Cytokine regulation of schistosome-induced granuloma and fibrosis. Kidney International 1997, 51:1370-1375.
54. Winterbourn C.C., Hawkins R.E., Brian M., Carrell R.W. The estimation of red cell superoxide dismutase activity. The Journal of Laboratory and Clinical Medicine 1975, 85:337-342.
55. Wynn T.A., Cheever A.W., Jankovic D., Poindexter R.W., Caspar P., Lewis F.A., Sher A. An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 1995, 376:594-596.
56. Xiong L.J., Zhu J.F., Luo D.D., Zen L.L., Cai S.Q. Effects of pentoxifylline on the hepatic content of TGF-β and collagen in schistosomiasis japonica mice with liver fibrosis. World Journal of Gastroenterology 2003, 9:152-154.
57. Zanetti G. Rabbit liver glutathione reductase: purification and properties. Archives of Biochemistry and Biophysics 1979, 198:241-246.